Skip to main content
. 2020 Feb 1;10(2):564–571.

Figure 2.

Figure 2

c-MET inhibitor induces PD-L1 expression in NSCLC cells in dose and time-dependent manner. A and B. Western blot analysis of whole cell lysates from H1993 and H1975 treated with the indicated concentrations of c-MET inhibitor tivantinib for 24 hours. C and D. Western blot analysis of whole cell lysates from H1993 and H1975 treated with c-MET inhibitor tivantinib (1 μM) for the indicated time. E. H1975 cells were treated with the indicated concentration of tivantinib for 24 hours followed by flow cytometric analysis of cell surface PD-L1 levels. F. H1975 cells were treated with tivantinib (1 μM) for the indicated time followed by flow cytometric analysis of cell surface PD-L1 levels.